EFFICACY OF HERPES SIMPLEX VACCINE--GD2T WITH MPL TO PREVENT GENITAL HERPES

单纯疱疹疫苗--GD2T 与 MPL 预防生殖器疱疹的功效

• 批准号: 6413650
• 负责人: STEPHEN K TYRING
• 金额: $ 27.93万
• 依托单位: UNIVERSITY OF TEXAS MED BR GALVESTON
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-12-01 至 2001-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6413650
• 关键词: Herpesviridae vaccine; chemoprevention; clinical research; clinical trial phase I; communicable disease control; communicable disease transmission; drug screening /evaluation; genital herpes; human middle age (35-64); human subject; human therapy evaluation; immunotherapy; placebos; sex partner; young adult human (21-34)

This is a double-blind, randomized, placebo-controlled study to evaluate the efficacy of a herpes simplex vaccine (gD2t) with MPL to prevent genital herpes disease in healthy adults, male and female, aged 18-45 years whose partner has clinical genital herpes disease.

这是一项双盲、随机、安慰剂对照研究，旨在评估单纯疱疹疫苗 (gD2t) 与 MPL 预防生殖器疱疹疾病的功效，对象为健康成人（男性和女性，年龄 18-45 岁，其伴侣患有临床生殖器疾病）疱疹病。